Castle Biosciences CSTL Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $339.92M-1.3% | $344.23M+0.2% | $343.53M-0.8% | $346.27M-0.2% | $347.08M+4.5% | ||
| $75.18M+5.8% | $71.03M+3.1% | $68.9M+4.7% | $65.8M+5.0% | $62.69M+4.1% | ||
| $53.69M+3.5% | $51.85M+3.5% | $50.11M+1.3% | $49.47M-2.7% | $50.82M-2.3% | ||
| $235.6M+2.7% | $229.32M+3.0% | $222.56M+2.5% | $217.15M+3.3% | $210.17M+5.1% | ||
| -$33.29M+22.2% | -$42.81M-22.5% | -$34.93M-51.6% | -$23.05M-67.2% | -$13.79M-259% | ||
| -9.8%+2.6pp | -12.4%-2.3pp | -10.2%-3.5pp | -6.7%-2.7pp | -4%-6.6pp | ||
| $203K+136% | $86K-44.2% | $154K-53.5% | $331K-42.9% | $580K+0.5% | ||
| -$295K-305% | $144K+200% | $48K— | $0— | —— | ||
| -$4.82M+9.9% | -$5.36M— | —— | —— | —— | ||
| -$12.83M+46.9% | -$24.16M-97.4% | -$12.24M-29.3% | -$9.47M-86.7% | -$5.07M-128% | ||
| -3.8%+3.2pp | -7%-3.5pp | -3.6%-0.8pp | -2.7%-1.3pp | -1.5%-7.0pp | ||
| -$0.43+48.8% | -$0.84-86.7% | -$0.45-28.6% | -$0.35-84.2% | -$0.19-131% | ||
| -$18.35M-800% | -$2.04M-126% | $7.83M-59.7% | $19.44M-32.1% | $28.63M+16.1% | ||
| -5.4%-4.8pp | -0.6%-2.9pp | 2.3%-3.3pp | 5.6%-2.6pp | 8.2%+0.8pp | ||
| -$33.29M+22.2% | -$42.81M-22.5% | -$34.93M-51.6% | -$23.05M-67.2% | -$13.79M-259% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Castle Biosciences's revenue?
- Castle Biosciences (CSTL) generated $339.9M in revenue over the trailing twelve months, down 2.1% year over year.
- Is Castle Biosciences profitable?
- Castle Biosciences is not currently profitable: it reported a net loss of $12.8M over the trailing twelve months, a -3.8% net margin.
- What are Castle Biosciences's profit margins?
- Gross margin is 77.9% and operating margin is -9.8%, with a -3.8% net margin.
- What is Castle Biosciences's earnings per share?
- Castle Biosciences's diluted EPS over the trailing twelve months is $-0.43.
- Where does Castle Biosciences's income statement data come from?
- Every line is extracted from Castle Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
